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Abstract:  Escherichia  coli-derived  glutamate  decarboxylase  (GAD),  an  enzyme  that 
catalyzes the conversion of glutamic acid to gamma-aminobutyric acid (GABA), was fused 
to  the  cellulose-binding  domain  (CBD)  and  a  linker  of  Trichoderma  harzianum 
endoglucanase  II.  To  prevent  proteolysis  of  the  fusion  protein,  the  native  linker  was 
replaced with a S3N10 peptide known to be completely resistant to E. coli endopeptidase. 
The CBD-GAD expressed in E. coli was successfully immobilized on Avicel, a crystalline 
cellulose, with binding capacity of 33 ±  2 nmolCBD-GAD/gAvicel and the immobilized enzymes 
retained 60% of their initial activities after 10 uses. The results of this report provide a 
feasible alternative to produce GABA using immobilized GAD through fusion to CBD. 
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1. Introduction  
Glutamate  decarboxylase  (GAD,  EC  4.1.1.15)  catalyzes  the  conversion  of  glutamic  acid  to  
gamma-aminobutyric acid (GABA) by consuming one intracellular proton and pyridoxal 5'-phosphate 
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(PLP) as a cofactor and producing CO2. GADs are ubiquitously found throughout the biological world 
from microorganisms to mammals [1]. GABA plays important physiological roles such as an inhibitory 
neurotransmitter with hypotensive, diuretic, and analgesic effects in the mammalian central nervous 
system  [2–4],  and  is  also  involved  in  an  acid-tolerance  mechanism  in  microorganisms  [5].This 
molecule can also be easily lactamized into 2-pyrrolidone, the precursor of nylon 4 [6,7], which has 
brought attention to GAD as a key component of GABA production through an enzymatic process. 
Among microbial GADs, E. coli-derived GAD (EcGAD) is a well-characterized enzyme [8–11]. 
EcGAD possesses some superior enzymatic characteristics including a high affinity for substrate and 
high reaction rate compared to other GADs [1,4]. Some studies have focused on potential for industrial 
applications  of  EcGAD  by  improving  its  enzymatic  properties  and  reaction  conditions  [6,9,12]. 
However,  few  studies  have  been  performed  on  the  immobilization  of  EcGAD  for  reuse  [7];  in 
particular, there is no report of experiments using an affinity tag. 
Most cellulose-degrading enzymes contain three domains: a cellulose-binding domain (CBD), a 
flexible  linker  region,  and  a  catalytic  domain.  [13–15].  The  catalytic  and  CBDs,  connected  by  a 
flexible polypeptide linker, participate in hydrolyzing and binding to cellulose, respectively. Some 
CBDs  have  been  developed  as  a  versatile  tag  for  affinity  procedures  due  to  their  specific  and 
irreversible cellulose-binding capabilities. Cellulose is relatively cheap, chemically inert, commercially 
available in many different forms and has a low non-specific affinity for most proteins [14,16–18].  
In this study, EcGAD was fused to the CBD from Trichoderma harzianum endoglucanse II (THEG). 
The GAD activity and cellulose-binding property of the fusion protein were investigated. Moreover, 
immobilization of this construct to a cellulose matrix was evaluated. 
2. Results and Discussion 
2.1. Expression of GAD Fused to CBD in E. coli 
For  the  fusion  of  EcGAD  with  CBD,  the  pEKPM-CBD-Lk-EcGAD-H6  expression  vector  was 
constructed (Figure 1). In this vector, EcGAD was fused to CBD and native linker of T. harziaum 
endoglucanase II [19] at its N-terminus and six histidine at its C-terminus, and the fused gene was 
placed under the control of a T7 promoter. GAD was expressed in E. coli BL21(DE3) harboring 
pEKPM-CBD-Lk-EcGAD-H6 through IPTG induction. As shown in Figure 2, two distinct bands were 
observed by SDS-PAGE, indicating that the fusion protein was partially degraded. N-terminal amino 
acid sequence analysis confirmed that proteolytic cleavage occurred in linker region (-ATTM↓STTT-, 
↓ indicates cleavage site). This phenomenon might be related to the fact that inter-domain linkers are 
particularly susceptible to proteolysis [12]. The reason is that flexible regions can more easily adopt 
conformations compatible with the active site of endopeptidase [12]. 
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Figure 1. A schematic representation of the expression vector for CBD-GAD-H6 fusion 
protein. E. coli-derived glutamate decarboxylase (EcGAD), glutamate decarboxylase from  
E.  coli;  CBD  and  linker,  the  cellulose-binding  and  linker  domains  of  T.  harzianum 
endoglucanase II; (His)6, 6×  histidine tag sequence; T7lac, T7 promoter sequence; T7t, T7 
terminator sequence. 
 
Figure 2. Expression of GAD fused to CBD in E. coli. Lane M, molecular weight (Mw) 
marker; lane T, total protein from the induced cells. The arrows indicate the position of the 
expressed GAD proteins. 
 
2.2. Modification of the Linker Peptide Connecting CBD with GAD 
In order to prevent proteolytic cleavage of the linker peptide, a native linker peptide was replaced 
with a S3N10 peptide known to completely resist E. coli endopeptidase [12]. As shown in Figure 3A, 
the  fusion  protein  with  a  S3N10  linker  was  successfully  expressed  without  being  degraded  by 
proteolysis, which was confirmed by N-terminal amino acid sequencing. However, analysis of the 
cellular fraction from induced cells showed that most of the fusion proteins were expressed as an 
insoluble  form.  To  increase  the  solubility,  the  transformants  were  cultured  at  a  low  temperature  
(at 18 °C ) and gene expression was induced by lactose (Figure 3B). 
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Figure 3. Expression of GAD fused to CBD with a modified linker in E. coli at 37 ° C (A) 
and 18 ° C (B). Lane M, Mw marker; lane T, total protein from the induced cells; lane S, 
soluble fraction from the induced cells; lane I, insoluble fraction from the induced cells. 
The arrows indicate the position of the CBD-GAD-H6 protein expressed in E. coli. 
 
2.3. Immobilization of CBD-GAD to the Cellulose Matrix 
The  soluble  CBD-GAD  fusion  protein  was  purified  using  a  Ni-NTA  column  and  eluted  by  a 
stepwise gradient of imidazole. The imidazole fraction (250 mM) contained a 58 kDa protein corresponding 
to CBD-GAD with a purity of 84% (Figure 4). The specific activity of the purified CBD-GAD was 
24.44  ±  0.77  U/mg,  which  was  lower  than  the  GAD  fused  to  six  histidine  (35.01  ±  1.03  U/mg) 
expressed  in  E.  coli  in  this  study.  The  purified  enzyme  was  used  to  evaluate  the  adsorption  
isotherm of CBD-GAD on Avicel (Figure 5). The cellulose-binding capacity was calculated to be  
33  ±   2  nmolCBD-GAD/gAvicel;  this  was  relatively  low  compared  to  other  CBD-fusion  proteins  
(0.082–1.10 μmol/g) reported in previous studies [20–22]. This low binding capacity might have been 
attributed  to  be  due  to  steric  hindrance  by  the  use  of  modified  linker  or  the  complex  nature  of  
CBD-GAD. The reusability of the GAD immobilized on Avicel was determined by comparing its 
relative activity after several uses. As shown in Figure 6, the immobilized GAD retained about 60% of 
its initial activity after ten consecutive uses. 
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Figure 4. Purification of CBD-GAD using His-tag affinity chromatography. Lane M, Mw 
marker;  lane  1,  soluble  fraction  from  the  induced  cells;  lane  2,  flow-through  fraction;  
lane 3, washed fraction; lane 4, purified CBD-GAD. The arrow indicates the position of the 
purified CBD-GAD-H6 protein.  
 
Figure  5.  Adsorption  isotherm  for  binding  of  CBD-GAD  to  Avicel.  Adsorptions  were 
evaluated in 20 mM sodium acetate buffer at pH 6.0 and room temperature. [CBD-GAD]Bound 
and [CBD-GAD]Free are the concentration of bound enzyme (nmolCBD-GAD/gAvicel) and free 
enzyme (nM), respectively. 
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Figure 6. Thin layer chromatography (A) and relative activity (B) of GAD immobilized on 
Avicel after multiple uses. After the enzyme reaction was preceded at 37 °C  for 30 min at 
pH 4.0, the immobilized enzyme was recovered by centrifugation and repeatedly re-used. 
The Avicel recovery was estimated to be about 99.7% at each step. S, standard for GABA 
and monosodium glutamate (MSG); number, recycled times.  
 
(B) 
Recycles
0 2 4 6 8 10
Relati
ve acti
vit
y (%)
0
20
40
60
80
100
120
 
3. Experimental Section  
3.1. Bacterial Srains 
E. coli DH5α [F
−, 80dlacZΔM15, endA1 hsdR17(rK
−, mK
+), supE44, thi-1, 
−, recA1, gyrA96] 
was used as the host strain for cloning and plasmid maintenance. E. coli BL21 [F
−, hsdS, gal, ompT, 
rB
−, mB
−] (Novagen, USA) harboring a lambda derivative, DE3, was used for the expression of GAD. 
3.2. Plasmid Construction 
For the efficient cloning work and use of kanamycin as a selective marker, DNA region between 
BglII and NdeI in pET-28b(+) was replaced by the region between same enzyme sites in pET-22b(+), 
which  created  a  modified  pET-28b(+).  For  the  CBD-GAD  fusion,  the  gene  encoding  CBD  
and  linker  of  THEG  were  amplified  from  pGAL-CBD-Lipase  [19]  using  a  forward  primer  Int. J. Mol. Sci. 2012, 13  364 
 
 
(5′-GAAGGAGATATACATATGCAGCAAACTGTTTGGGGGCAA-3′)  and  a  reverse  primer  
(5′-ACGGAGCTCGAATTCGGATCCAGAGCTAGTTGGCGGAGTAGC-3′) in which the underlined 
characters were introduced for in-fusion ligation. The polymerase chain reaction (PCR) product was 
ligated into the modified pET-28b(+) plasmid (Novagen, USA) digested with NdeI and BamHI using 
the  In-fusion™  Advantage  PCR  cloning  kit  (Clontech,  USA).  The  resulting  plasmid  was  named 
pEKPM-CBD. The GAD gene was amplified from E. coli genomic DNA by PCR using a forward 
primer  (5′-ACTCCGCCAACTAGCTCTGGATCCGATAAGAAGCAAGTAACG-3′)  and  a  reverse 
primer (5′-GTGGTGGTGGTGGTGGTGCTCGAGGGTATGTTTAAAGCT-3′) in which the underlined 
base pairs were introduced for in-fusion ligation. The PCR product was ligated into the pEKPM-CBD 
plasmid previously digested with BamHI and XhoI using the In-fusion™ Advantage PCR cloning kit, 
which created pEKPM-CBD-Lk-EcGAD-H6. To replace the native linker peptide with S3N10 linker 
sequence  as  suggested  by  Kavoosi  et  al.  [12],  CBD  with  the  S3N10  linker  are  amplified  from  
pEKPM-CBD-Lk-EcGAD-H6 using the specific primers (forward: 5′-GAAGGAGATATACATATG 
CAGCAAACTGTTTGGGGG-3′, reverse: 5′-CTTCTTATCGGATCC GTTGTTGTTGTTGTTGTTGT 
TGTTGTTGTTGCTGCTGCTAATGCATTGAGCGTAGTA-3′  in  which  the  underlined  characters 
were introduced for in-fusion ligation). The PCR products containing CBD and the S3N10 linker were 
ligated into pEKPM-CBD-Lk-EcGAD-H6 previously digested with NdeI and BamHI, which created 
pEKPM-CBD-mLk-EcGAD-H6. 
For GAD protein without CBD, the GAD gene was amplified from E. coli genomic DNA by PCR 
using  a  forward  primer  (5′-GAAGGAGATATACATATGGATAAGAAGCAAGTAACG-3′)  and  a 
reverse primer (5′-GTGGTGGTGGTGGTGGTGCTCGAGGGTATGTTTAAAGCT-3′) in which the 
underlined base pairs were introduced for in-fusion ligation. The PCR product was ligated into the 
modified  pET-28b(+)  plasmid  previously  digested  with  BamHI  and  XhoI  using  the  In-fusion™ 
Advantage PCR cloning kit, which created pEKPM-GAD-H6. 
3.3. Expression of CBD-GAD  
Transformants were cultured overnight in a test tube containing 2 mL of Luria-Bertani (LB) media 
with kanamycin (50 μg/mL) at 37 ° C. The culture was then transferred to 1 L baffled flasks containing 
200 mL of LB media supplemented with kanamycin (50 μg/mL). When cell density reached an optical 
density (OD) of 0.5 at 600 nm as measured by a spectrophotometer (UVICON, Switzerland), induction 
was initiated with 0.4 mM IPTG for 3 h. After IPTG induction, the cells were harvested and lysed by 
sonication for further analysis. Proteins in the lysates were separated by SDS-PAGE according to the 
method by Laemmli [23] on 10% polyacrylamide gels using a mini-gel apparatus (Hoefer, USA). The 
separated proteins were stained with Coomassie blue. For culturing at low temperature, the transformants 
were cultured using the protocol described above at 37 ° C to an OD of 0.5 and induced overnight with 
0.1% (w/v) lactose.  
3.4. N-Terminal Amino Acid Sequencing 
CBD-GAD-H6 was isolated using SDS-PAGE, and the corresponding bands were transferred to a 
PVDF (polyvinylidene fluoride) membrane using a semi-dry electroblotter (TE 77 PWR, Amersham 
Bioscience, UK). The membrane was stained with Ponceau S (AMRESCO, USA) to visualize the Int. J. Mol. Sci. 2012, 13  365 
 
 
GAD  bands  and  N-terminal  amino  acid  sequencing  was  performed  by  the  Korea  Basic  Science 
Institute (Republic of Korea).  
3.5. Purification of CBD-GAD and GAD Protein 
The transformants were harvested by centrifugation. The cells were then resuspended in B-PER
®II 
reagent (bacterial protein extraction reagent, Pierce, USA) to extract soluble proteins. The supernatant 
was  collected  for  purification;  nickel  affinity  chromatography  using  Ni-NTA  resin  (HisTrap,  GE 
Healthcare, UK) was performed to purify CBD-GAD and GAD proteins. The bound proteins were 
eluted with a three-step gradient of imidazole (12.5, 25, and 250 mM) in 20 mM sodium phosphate 
buffer with 0.5 M NaCl, pH 7.4. Fractions collected at each step were analyzed by 10% SDS-PAGE. 
Purified proteins were dialyzed overnight against 20 mM sodium phosphate buffer (pH 7.4) at 4 °C . 
3.6. Assay of GAD Activity 
Enzymatic activities were measured by a 718 Stat Titrino (Metrohm, Switzerland) with an aqueous 
solution of 0.1 M HCl. The solution containing MSG of 0.1M and PLP of 0.02 mM was adjusted to 
final  pH  of  4.0  and  an  enzyme  was  added.  The  enzyme  reaction  was  performed  at  37  °C   while 
recording  the  titration.  Activities  were  calculated  by  the  slope  of  the  titration  curve  over  5  min.  
One unit was defined as the amount of enzyme required for being added 1 μmol H
+ per minute under 
assay conditions.  
3.7. Adsorption Isotherm Measurements 
To  estimate  the  binding  capacity  of  CBD-GAD  attached  to  the  Avicel,  adsorption  isotherm 
measurements  were  taken  at  room  temperature  in  1.5  mL  Eppendorf  tubes.  Samples  containing  
0–60 nM of CBD-GAD and 0.2 mg of Avicel were mixed with 20 mM sodium acetate buffer (pH 6.0) 
in a final aqueous volume of 1.2 mL. Each solution was incubated for 1 h to allow the adsorption to 
saturate.  The  supernatants  were  collected  by  centrifugation  and  the  protein  concentration  was 
measured using a BCA protein assay kit (Pierce, USA). This value was then subtracted from the initial 
amount  of  protein  added  to  the reaction tube and  the difference was considered to be  amount  of 
proteins adsorbed onto Avicel. All values were measured in triplicate.  
3.8. Reusability Assay of Immobilized GAD 
Relative quantification of retained activities after use of immobilized GAD was performed by TLC 
combined with image analyzer. Samples were prepared as follows; Enzyme was added into the 100 
mM MSG and 0.02 mM PLP in 20 mM sodium acetate buffer (pH 4.0). After enzyme reaction at 
37 °C for 30 min, immobilized enzyme was recovered by centrifugation and re-used after washing 
with sodium acetate buffer (pH 4.0). The loss of enzyme molecules due to the recovery process was 
calculated as 0.3% at each step. The supernatants after enzyme reaction and GABA standard solution 
were spotted on 10 cm ×  10 cm glass TLC plates precoated with 60F254 silica gel (Merck, Germany). 
The mobile phase was prepared by mixing n-butanol/acetic acid/water (5/3/2, v/v/v). The plates were 
developed by applying ninhydrin reagent (Fluka, Switzerland) then dried at 80 °C  for 5 min. The Int. J. Mol. Sci. 2012, 13  366 
 
 
image analysis of the spot on the plate was processed by TotalLap TL100 Image Analysis Software 
(Nonlinear Dynamics, UK). 
4. Conclusions 
In conclusion, we succeeded in producing recombinant E. coli which can express relatively high-
level  of  GAD  fused  to  CBD  with  a  histag  to  facilitate  purification  as  soluble  forms  through  the 
modification  of  linker  peptide  and  low  temperature  culture  condition.  This  bifunctional  chimeric 
protein simultaneously showed both GAD activity and cellulose-binding ability, which allowed it to be 
immobilized on a cellulose matrix. To our knowledge, this is the first report on the immobilization of 
GAD  using  affinity-tag  to  obtain  GABA  by  bio-conversion.  Applying  of  low-priced  cellulose  as 
matrix and reutilizing of enzyme due to immobilization can be accompanied by decrease in cost. The 
presented process, therefore, can be potentially applicable to produce GABA in large-scale. 
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